These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2064828)

  • 21. Current approaches to vaccination against human immunodeficiency viruses.
    Gluckman JC; Yagello M; Bahraoui E; Girard M
    Allergol Immunopathol (Madr); 1991; 19(1):11-3. PubMed ID: 1719790
    [No Abstract]   [Full Text] [Related]  

  • 22. Serological detection of attenuated HIV-1 variants with nef gene deletions.
    Greenway AL; Mills J; Rhodes D; Deacon NJ; McPhee DA
    AIDS; 1998 Apr; 12(6):555-61. PubMed ID: 9583594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of human immunodeficiency virus type 1 nef gene product expressed by a recombinant baculovirus.
    Matsuura Y; Maekawa M; Hattori S; Ikegami N; Hayashi A; Yamazaki S; Morita C; Takebe Y
    Virology; 1991 Oct; 184(2):580-6. PubMed ID: 1909480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection.
    Bahraoui E; Benjouad A; Sabatier JM; Allain JP; Laurian Y; Montagnier L; Gluckman JC
    Blood; 1990 Jul; 76(1):257-64. PubMed ID: 1694699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.
    Harrer E; Bäuerle M; Ferstl B; Chaplin P; Petzold B; Mateo L; Handley A; Tzatzaris M; Vollmar J; Bergmann S; Rittmaier M; Eismann K; Müller S; Kalden JR; Spriewald B; Willbold D; Harrer T
    Antivir Ther; 2005; 10(2):285-300. PubMed ID: 15865223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HIV-1 Nef protein shares an antigenic determinant with a T-cell surface protein.
    Scheider T; Beck A; Röpke C; Ullrich R; Harthus HP; Bröker M; Pauli G
    AIDS; 1993 May; 7(5):647-54. PubMed ID: 7686375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the antigenic structure of human immunodeficiency virus using synthetic peptides].
    Ivanov VS; Chikin LD; Suvorova ZK; Kozhich AT; Ivanov VT
    Bioorg Khim; 1992 Jun; 18(6):784-93. PubMed ID: 1384509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Nef protein regulates productive HIV-1 infection from latency.
    Fujinaga K; Zhong Q; Nakaya T; Kameoka M; Meguro T; Yamada K; Ikuta K
    J Immunol; 1995 Dec; 155(11):5289-98. PubMed ID: 7594542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
    Hadida F; Haas G; Zimmermann N; Hosmalin A; Spohn R; Samri A; Jung G; Debre P; Autran B
    J Immunol; 1995 Apr; 154(8):4174-86. PubMed ID: 7535824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of single-chain antibodies that bind an overlapping epitope of HIV-1 Nef.
    Chang AH; Hoxie JA; Cassol S; O'Shaughnessy M; Jirik F
    FEBS Lett; 1998 Dec; 441(2):307-12. PubMed ID: 9883905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifying the antigen-immunization schedule improves the variety of monoclonal antibodies obtained from immune-phage antibody libraries against HIV-1 Nef and Vif.
    Yoshikawa M; Mukai Y; Tsunoda S; Tsutsumi Y; Yoshioka Y; Okada N; Nakagawa S
    J Biosci Bioeng; 2011 May; 111(5):597-9. PubMed ID: 21277253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies.
    Ovod V; Lagerstedt A; Ranki A; Gombert FO; Spohn R; Tähtinen M; Jung G; Krohn KJ
    AIDS; 1992 Jan; 6(1):25-34. PubMed ID: 1371924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of a mouse monoclonal antibody against the Gag p26 protein of human immunodeficiency virus type 2: identification of a new antigenic epitope.
    Marcelino JM; Novo C; Pereira JM; Picotez F; Clemente A; Taveira N
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1279-83. PubMed ID: 11559428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth dominance of a revertant virus generated during in vitro serial passage of nef frameshift mutant of HIV-1.
    Fujinaga K; Nakamura Y; Zhong Q; Nakaya T; Ikuta K
    Biochem Biophys Res Commun; 1996 Dec; 229(1):96-101. PubMed ID: 8954089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency of antibodies against recombinant HIV-2 Nef protein in HIV-2-positive and HIV-negative sera.
    Mayer J; Kienzle N; Ulrich R; Hunsmann G; Mueller-Lantzsch N
    AIDS; 1992 May; 6(5):519-20. PubMed ID: 1616664
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes.
    Kohleisen B; Neumann M; Herrmann R; Brack-Werner R; Krohn KJ; Ovod V; Ranki A; Erfle V
    AIDS; 1992 Dec; 6(12):1427-36. PubMed ID: 1301062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Ranki A; Järvinen K; Valle SL; Nurmilaakso P; Krohn K
    J Acquir Immune Defic Syndr (1988); 1990; 3(4):348-55. PubMed ID: 2179525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleotide and amino acid homology between the human thyrotropin receptor and the HIV-1 Nef protein: identification and functional analysis.
    Burch HB; Nagy EV; Lukes YG; Cai WY; Wartofsky L; Burman KD
    Biochem Biophys Res Commun; 1991 Nov; 181(1):498-505. PubMed ID: 1958218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.